"Neurofibromatosis 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
Descriptor ID |
D016518
|
MeSH Number(s) |
C04.557.465.625.650.595.610.500 C04.557.580.600.580.590.655 C04.557.580.600.610.595.610.500 C04.700.645.655 C09.218.807.800.675.500 C09.647.675.500 C10.292.225.750.500 C10.292.910.600.500 C10.562.600.750 C10.574.500.549.700 C16.320.400.560.700 C16.320.700.645.655
|
Concept/Terms |
Neurofibromatosis 2- Neurofibromatosis 2
- Neurofibromatosis, Central, NF2
- Neurofibromatosis, Central, NF 2
- Bilateral Acoustic Neurofibromatosis
- Acoustic Neurofibromatoses, Bilateral
- Acoustic Neurofibromatosis, Bilateral
- Bilateral Acoustic Neurofibromatoses
- Neurofibromatoses, Bilateral Acoustic
- Neurofibromatosis, Bilateral Acoustic
- Neurofibromatosis II
- Neurofibromatosis IIs
- Neurofibromatosis, central type
- Neurofibromatosis Type 2
- Neurofibromatosis, Type II
- Neurofibromatoses, Type II
- Type II Neurofibromatoses
- Type II Neurofibromatosis
- Neurofibromatosis, Type 2
- Neurofibromatoses, Type 2
- Type 2 Neurofibromatoses
- Type 2 Neurofibromatosis
- NF2 (Neurofibromatosis 2)
- NF2s (Neurofibromatosis 2)
- Neurofibromatosis, Central NF2
- Central NF2 Neurofibromatoses
- Central NF2 Neurofibromatosis
- Neurofibromatoses, Central NF2
- Central Neurofibromatosis
- Central Neurofibromatoses
- Neurofibromatoses, Central
- Neurofibromatosis, Central
- Neurofibromatosis, Acoustic, Bilateral
- Neurofibromatosis Type II
Neuroma, Acoustic, Bilateral- Neuroma, Acoustic, Bilateral
- Acoustic Neurinoma, Bilateral
- Acoustic Neurinomas, Bilateral
- Bilateral Acoustic Neurinoma
- Bilateral Acoustic Neurinomas
- Neurinoma, Bilateral Acoustic
- Neurinomas, Bilateral Acoustic
Schwannoma, Acoustic, Bilateral- Schwannoma, Acoustic, Bilateral
- Acoustic Schwannomas, Bilateral
- Acoustic Schwannoma, Bilateral
- Bilateral Acoustic Schwannoma
- Bilateral Acoustic Schwannomas
- Schwannoma, Bilateral Acoustic
- Schwannomas, Bilateral Acoustic
Familial Acoustic Neuromas- Familial Acoustic Neuromas
- Acoustic Neuroma, Familial
- Acoustic Neuromas, Familial
- Familial Acoustic Neuroma
- Neuroma, Familial Acoustic
- Neuromas, Familial Acoustic
|
Below are MeSH descriptors whose meaning is more general than "Neurofibromatosis 2".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Germ Cell and Embryonal [C04.557.465]
- Neuroectodermal Tumors [C04.557.465.625]
- Neuroendocrine Tumors [C04.557.465.625.650]
- Neurilemmoma [C04.557.465.625.650.595]
- Neuroma, Acoustic [C04.557.465.625.650.595.610]
- Neurofibromatosis 2 [C04.557.465.625.650.595.610.500]
- Neoplasms, Nerve Tissue [C04.557.580]
- Nerve Sheath Neoplasms [C04.557.580.600]
- Neurofibroma [C04.557.580.600.580]
- Neurofibromatoses [C04.557.580.600.580.590]
- Neurofibromatosis 2 [C04.557.580.600.580.590.655]
- Neuroma [C04.557.580.600.610]
- Neurilemmoma [C04.557.580.600.610.595]
- Neuroma, Acoustic [C04.557.580.600.610.595.610]
- Neurofibromatosis 2 [C04.557.580.600.610.595.610.500]
- Neoplastic Syndromes, Hereditary [C04.700]
- Neurofibromatoses [C04.700.645]
- Neurofibromatosis 2 [C04.700.645.655]
- Otorhinolaryngologic Diseases [C09]
- Ear Diseases [C09.218]
- Retrocochlear Diseases [C09.218.807]
- Vestibulocochlear Nerve Diseases [C09.218.807.800]
- Neuroma, Acoustic [C09.218.807.800.675]
- Neurofibromatosis 2 [C09.218.807.800.675.500]
- Otorhinolaryngologic Neoplasms [C09.647]
- Neuroma, Acoustic [C09.647.675]
- Neurofibromatosis 2 [C09.647.675.500]
- Nervous System Diseases [C10]
- Cranial Nerve Diseases [C10.292]
- Cranial Nerve Neoplasms [C10.292.225]
- Neuroma, Acoustic [C10.292.225.750]
- Neurofibromatosis 2 [C10.292.225.750.500]
- Vestibulocochlear Nerve Diseases [C10.292.910]
- Neuroma, Acoustic [C10.292.910.600]
- Neurofibromatosis 2 [C10.292.910.600.500]
- Neurocutaneous Syndromes [C10.562]
- Neurofibromatoses [C10.562.600]
- Neurofibromatosis 2 [C10.562.600.750]
- Neurodegenerative Diseases [C10.574]
- Heredodegenerative Disorders, Nervous System [C10.574.500]
- Neurofibromatoses [C10.574.500.549]
- Neurofibromatosis 2 [C10.574.500.549.700]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Heredodegenerative Disorders, Nervous System [C16.320.400]
- Neurofibromatoses [C16.320.400.560]
- Neurofibromatosis 2 [C16.320.400.560.700]
- Neoplastic Syndromes, Hereditary [C16.320.700]
- Neurofibromatoses [C16.320.700.645]
- Neurofibromatosis 2 [C16.320.700.645.655]
Below are MeSH descriptors whose meaning is more specific than "Neurofibromatosis 2".
This graph shows the total number of publications written about "Neurofibromatosis 2" by people in this website by year, and whether "Neurofibromatosis 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 0 | 1 |
2008 | 1 | 1 | 2 |
2010 | 2 | 2 | 4 |
2011 | 3 | 0 | 3 |
2012 | 1 | 0 | 1 |
2013 | 1 | 1 | 2 |
2014 | 2 | 0 | 2 |
2016 | 0 | 1 | 1 |
2017 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neurofibromatosis 2" by people in Profiles.
-
Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2. Curr Oncol. 2023 03 14; 30(3):3355-3365.
-
Pediatric laryngeal electromyography technique for vocal fold immobility using bipolar double hookwire electrodes. Int J Pediatr Otorhinolaryngol. 2019 Apr; 119:75-78.
-
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Am J Med Genet A. 2018 05; 176(5):1258-1269.
-
Calvarial mass as a presenting feature of neurofibromatosis type 2 in a pediatric patient. Am J Med Genet A. 2018 01; 176(1):246-247.
-
Clinical Reasoning: A common cause for Phelan-McDermid syndrome and neurofibromatosis type 2: One ring to bind them. Neurology. 2017 10 24; 89(17):e205-e209.
-
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. Nat Commun. 2016 10 07; 7:13131.
-
Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome. Discov Med. 2014 Dec; 18(101):323-30.
-
Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. Cancer Cell. 2014 Jul 14; 26(1):48-60.
-
NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations. Oncotarget. 2014 Jan 15; 5(1):67-77.
-
Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet. 2014 Feb; 46(2):182-7.